Скачать или смотреть George & Lucy: A Patient’s Path to FOTIVDA® (tivozanib)

Please see full Prescribing Information: https://spr.ly/fotivdaPI. Learn from a patient’s experience through his treatment journey with renal cell carcinoma (RCC).

IMPORTANT PRODUCT INFORMATION

FOTIVDA® (tivozanib) is a medicine used to treat adults with advanced kidney cancer that has been treated with 2 or more prior medicines and has come back or did not respond to treatment.

FOTIVDA can cause serious side effects including high blood pressure, heart failure, heart attack and blood clots in your veins or arteries, bleeding problems, protein in your urine, tears in your stomach or intestines, thyroid gland problems, and risk of wound-healing problems. Tell your health care provider if you have headaches, seizures, confusion, blindness or changes in vision, or difficulty thinking, which could be a sign of reversible posterior leukoencephalopathy syndrome. Call or see your healthcare provider right away if you develop any of these signs or symptoms or if they get worse.

FOTIVDA contains a dye called FD&C Yellow No. 5 (tartrazine) that may cause allergic-type reactions, including bronchial asthma, in certain people.

The most common side effects of FOTIVDA include tiredness, diarrhea, decreased appetite, nausea, hoarseness, low levels of thyroid, hormones, cough, mouth sores, decreased blood levels of salt (sodium) and phosphate, increased levels of lipase in the blood.

Please read the complete Prescribing Information for FOTIVDA and discuss it with your doctor.

To report suspected side effects, contact AVEO Pharmaceuticals, Inc. at 1-833-FOTIVDA (1-833-368-4832) of FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.

Chapters:
0:00 Intro from George, a patient with renal cell carcinoma (RCC)
0:53 George’s initial treatment journey
1:20 George’s cancer returns
2:21 Lucy gives a loved one’s perspective on living with RCC
3:00 RCC treatment with FOTIVDA
4:02 Words of encouragement for those with advanced kidney cancer